<?xml version='1.0' encoding='UTF-8'?><rdsi.pacelf.phase3:document xmlns:rdsi.pacelf.phase3='http://www.example.com' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' ><PacELF_ID>1254</PacELF_ID><type>Hardcopy</type><category>Scientific Papers</category><hardcopy_location>JCU WHOCC Ichimori collection; WHO Geneva</hardcopy_location><title>The role of albendazole in programmes to eliminate lymphatic filariasis</title><description>Citing earlier advances in the treatment of lymphatic filariasis [particularly the effectiveness of single-dose diethylcarbamazine (DEC) in reducing microfilaraemia and its enhanced effectiveness when co-administered with single-dose ivermectin], Eric Ottesen, Mahroof Ismail and John Horton consider recent studies on the antifilarial activity of albendazole that have led to the current recommendations for its use in single-dose regimens in conjunction with either DEC or ivermectin for large-scale control/elimination programmes. Furthermore, the potential of albendazole as a macrofilaricide for treating individual patients with lymphatic filarial infections is emphasized as one of a number of important research questions that remain to be explored.</description><year>1999</year><authors>Ottesen, E.A., Ismail, M.M., Horton, J.</authors><journal>Parasitology Today</journal><volume-issue>15(9)</volume-issue><pages>382-386</pages><work_location>Multicountry Global</work_location><language>English</language><access_rights>Restricted</access_rights><pdf_file_name>Multicountry Global/PacELF_1254 Ottesen 1999 PARASIT TODAY Role of albendazole 1-s2.0-S0169475899014866-main.pdf</pdf_file_name><decade>1990</decade></rdsi.pacelf.phase3:document>